Repositioning of bromocriptine for treatment of acute myeloid leukemia

BACKGROUND: Treatment for acute myeloid leukemia (AML) has not significantly changed in the last decades and new therapeutic approaches are needed to achieve prolonged survival rates. Leukemia stem cells (LSC) are responsible for the initiation and maintenance of AML due to their stem-cell propertie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Transl Med
Hlavní autoři: Lara-Castillo, María Carmen, Cornet-Masana, Josep Maria, Etxabe, Amaia, Banús-Mulet, Antònia, Torrente, Miguel Ángel, Nomdedeu, Meritxell, Díaz-Beyá, Marina, Esteve, Jordi, Risueño, Ruth M.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015257/
https://ncbi.nlm.nih.gov/pubmed/27604463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1007-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky